Tracon Pharmaceuticals, Inc. (17)

Browse by Contract Category

Contracts

Amendment #2 to Cooperative Research and Development Agreement by and between the Registrant and the U.S. Department of Health and Human Services, as represented by National... (Filed With SEC on February 25, 2021)
Employment Agreement by and between the Registrant and Mark Wiggins, dated January 27, 2021 (Filed With SEC on February 25, 2021)
Deferral agreement to Amended and Restated Loan and Security Agreement between the Registrant and Silicon Valley Bank dated April 10, 2020 (Filed With SEC on April 15, 2020)
Amendment One to License and Option Agreement between the Registrant and Janssen Pharmaceutica N.V. dated January 15, 2019 (Filed With SEC on March 1, 2019)
TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 29, 2021 (Filed With SEC on February 25, 2021)
TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 29, 2021 (Filed With SEC on February 25, 2021)
Employment Agreement by and between the Registrant and Scott Brown, dated January 28, 2020 (Filed With SEC on February 28, 2020)
Collaboration and Clinical Trial Agreement by and among the Registrant, 3D Medicines (Beijing) Co., LTD. and Jiangsu Alphamab Biopharmaceuticals Co., LTD. dated December 20, 2019 (Filed With SEC on February 28, 2020)
Severance Agreement by and between the Registrant and Scott Brown, dated December 4, 2019 (Filed With SEC on February 28, 2020)
TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 28, 2020 (Filed With SEC on February 28, 2020)
TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 31, 2020 (Filed With SEC on February 28, 2020)
Description of Capital Stock (Filed With SEC on February 28, 2020)
Amendment No. 1 to Capital on DemandTM Sales Agreement, dated as of February 28, 2019, by and between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on November 5, 2019)
Registration Rights Agreement, dated October 18, 2019, between TRACON Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
Employment Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)
Severance Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)
Amended and Restated Employment Agreement by and between the Registrant and Charles P. Theuer, M.D., Ph.D., dated February 5, 2019 (Filed With SEC on March 1, 2019)